ARCHIVES

Phase III Nexavar Trial Fails Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 37 No. 8 | August 29, 2014

Download PDF Visit The Full Archive

Related Articles

Garb Denies He, Panel Said Contract Should Be Primary Funding Mechanism

March 17, 1978

Cancer Center Directors to Develop Blueprint for Progress That’s “Honest,” M.D. Anderson’s John Mendelsohn Says.

November 22, 2006

Highlights of NCDDGs: 3 Drugs on Market, 12 in Development; Advisors Approve Plan to Issue $10.5 Million Contract For Pediatric Preclinical Testing Program

November 29, 2002

PROPOC Study Analyses Six Cancer DRGs

January 17, 1986

In Brief: Brandt Names To Health Position; Everett Koop Would Be Surgeon General In HHS Reorganization

February 20, 1981

NCI Issues 8 Awards, 12 Feasibility Grants, In New SPORE Program

October 9, 1992